Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUVA: Fluid Bolus vs Vasopressor for Intubation
NCT05318066Active, not recruiting
- Sponsor
- Tata Memorial Centre
- Start
- Jul 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of norepinephrine in hypotension and Cardiovascular collapse (2 arms), sponsored by Tata Memorial Centre. Primary endpoint: Cardiovascular collapse (composite outcome) at 1 hour. Started Jul 2022; status: active, not recruiting.
02
Drugs
norepinephrine
03
Conditions
hypotensionCardiovascular collapse
Beyond the preview
Go deeper on NCT05318066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05318066.